Literature DB >> 19706818

Complexity made simple in diffuse large B-cell lymphoma.

Jon Aster1, Jeffery Kutok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19706818      PMCID： PMC2737086          DOI： 10.1158/1078-0432.CCR-09-1444

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  12 in total

1.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

Review 2.  Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.

Authors:  C R Taylor; R M Levenson
Journal:  Histopathology       Date:  2006-10       Impact factor: 5.087

3.  Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.

Authors:  Craig H Moskowitz; Andrew D Zelenetz; Tarun Kewalramani; Paul Hamlin; Simone Lessac-Chenen; Jane Houldsworth; Adam Olshen; Raju Chaganti; Stephen Nimer; Julie Teruya-Feldstein
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

Review 4.  Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment I.

Authors:  R A Walker
Journal:  Histopathology       Date:  2006-10       Impact factor: 5.087

5.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

6.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

8.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

Review 10.  Commercialized multigene predictors of clinical outcome for breast cancer.

Authors:  Jeffrey S Ross; Christos Hatzis; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobágyi
Journal:  Oncologist       Date:  2008-05
View more
  3 in total

Review 1.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

2.  STAT3 promotes tumour progression in glioma by inducing FOXP1 transcription.

Authors:  Xinlin Sun; Jihui Wang; Min Huang; Taoliang Chen; Jiansheng Chen; Fabing Zhang; Huijun Zeng; Zhimin Xu; Yiquan Ke
Journal:  J Cell Mol Med       Date:  2018-08-22       Impact factor: 5.310

3.  MAb NJ001 inhibits lung adenocarcinoma invasiveness by directly regulating TIMP-3 promoter activity via FOXP1 binding sites.

Authors:  Chunrong Gu; Ying Luo; Shichang Zhang; Jian Xu; Jiexin Zhang; Huanyu Ju; Jingping Liu; Lixia Zhang; Yan Zhang; Lei Wu; Erfu Xie; Ting Xu; Shiyang Pan
Journal:  Thorac Cancer       Date:  2020-08-03       Impact factor: 3.500
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.